NeoProgen, Inc. is a pre-clinical company developing stem cell technology from allogeneic cardiac stem/progenitor cells (CPCs) generated from neonatal tissue for the treatment of adult heart failure, both in ischemic and non-ischemic conditions.

Contact NeoProgen